• Acetoacetic Acid Sodium Salt: Beyond Ketone Bodies in Metabo

  2026-07-17

  Explore the pivotal role of Acetoacetic acid sodium salt in advanced metabolic and diabetes research. This article delivers new scientific insights into sodium 3-oxobutanoate’s mechanistic value, bridging molecular assay design with translational relevance.

• (+)-Bicuculline Protocol Guide: GABAA Antagonist in Research

  2026-07-16

  (+)-Bicuculline is a classical GABAA receptor antagonist designed for dissecting inhibitory neurotransmission and modulating synaptic NMDA receptor signaling in neuroscience research. It is not suitable for diagnostic, therapeutic, or clinical applications. Adherence to handling, solubility, and storage protocols is required to ensure reliable experimental outcomes.

• CPI-613: Applied Workflows in Tumor Cell Metabolism Studies

  2026-07-16

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) delivers unique specificity for dissecting mitochondrial metabolism and apoptosis in tumor models. This guide translates bench research into actionable assay designs, troubleshooting, and protocol optimization for acute myeloid leukemia and non-small cell lung carcinoma studies.

• Cyclosporin A (B1922): Technical Protocols & Workflow Guidan

  2026-07-15

  Cyclosporin A (B1922) is a potent cyclophilin inhibitor essential for immunosuppression, apoptosis modulation, and mitochondrial function assays in cell and animal models. It should not be used in aqueous-only systems or for long-term solution storage without revalidation, due to solubility and stability constraints.

• MG-132 (Z-LLL-al): Precision Proteasome Inhibition in Transl

  2026-07-15

  Explore how MG-132 (Z-LLL-al), a potent, cell-permeable proteasome inhibitor, empowers translational researchers to dissect the ubiquitin-proteasome system at a mechanistic level. This thought-leadership article bridges recent cardiovascular findings, experimental protocols, and strategic guidance, positioning MG-132 from APExBIO as a foundation for breakthroughs in apoptosis, cell cycle arrest, and disease modeling.

• Applied Workflows with the TUNEL Apoptosis Detection Kit (DA

  2026-07-14

  Unlock sensitive, reproducible apoptosis quantification in tissue and cell models using the TUNEL Apoptosis Detection Kit (DAB) from APExBIO. This article details optimized protocols, real-world applications, and troubleshooting strategies, translating recent mechanistic breakthroughs into actionable research insights.

• CXCR4-Targeted Theranostic Strategies in Lymphoma: Imaging a

  2026-07-14

  This review articulates the rationale and recent advances in CXCR4-targeted imaging and therapeutic approaches for lymphoma. By dissecting the molecular underpinnings and translational impact of peptide-based radiotracers and CXCR4 antagonists, the study highlights how integrative theranostic strategies may improve precision diagnosis and overcome resistance in hematologic malignancies.

• Applied Workflows for Protein Labeling with Cy5 Maleimide

  2026-07-13

  Cy5 maleimide (non-sulfonated) empowers site-specific, high-contrast labeling of proteins and peptides, enabling unparalleled resolution in fluorescence imaging and molecular partitioning studies. This guide distills bench-tested protocols, troubleshooting strategies, and recent research into actionable steps for maximizing assay sensitivity and reproducibility.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody: Optimizing Biomark

  2026-07-13

  The FITC Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO sets a new benchmark in sensitive and reproducible biomarker detection for immunofluorescence and flow cytometry. By enabling robust signal amplification and low background, it unlocks advanced workflows in early disease biomarker research—especially for targets like HMGB1 in diabetic nephropathy.

• hiPSC-Derived Sensory Neurons Model HSV-1 Latency and Reacti

  2026-07-12

  This study establishes a scalable model for HSV-1 latent infection and reactivation using human sensory neurons differentiated from inducible pluripotent stem cells (hiPSCs). The approach enables direct investigation of neuron-specific mechanisms underlying herpesvirus latency and reactivation, addressing limitations of traditional animal models and advancing translational neurovirology.

• Fenofibrate as a PPARα Agonist: Optimizing Liver and Cancer

  2026-07-10

  Fenofibrate, a potent PPARα agonist supplied by APExBIO, enables age-independent activation of lipid metabolism and YAP signaling, empowering advanced liver and cancer biology workflows. This article delivers actionable protocols, troubleshooting strategies, and a practical translation of the latest reference study, positioning Fenofibrate as a cornerstone for reproducible, cutting-edge research.

• Trolox: Benchmarking Antioxidant Capacity in Applied Researc

  2026-07-09

  Trolox, a cell-permeable vitamin E analogue, is pivotal for precise quantification of antioxidant activity across oxidative injury, neurodegeneration, and bioactive packaging workflows. This guide translates recent advances into actionable protocols and troubleshooting insights, leveraging Trolox’s unique properties for robust, reproducible results.

• Morning Endurance Training Yields Superior Adaptation in Mic

  2026-07-09

  Hesketh et al. investigated how the timing of endurance exercise training—morning versus afternoon—affects performance adaptations in mice. Their findings reveal that morning training drives greater relative improvements in endurance and muscle metabolic adaptation, highlighting exercise timing as a critical variable in experimental and translational research.

• NADPH Oxidase-ROS and LTCC Drive Arterial Contraction in Neo

  2026-07-08

  A recent study reveals that reactive oxygen species (ROS) generated by NADPH oxidase promote arterial contraction in early postnatal rats through activation of L-type voltage-gated Ca2+ channels (LTCC), independently of Rho-kinase, PKC, or Src-kinase. These findings clarify the mechanistic basis for ROS-mediated vascular tone regulation in neonates and refine targets for future signaling pathway research.

• BIBP 3226 trifluoroacetate: Precision in NPY/NPFF System Res

  2026-07-08

  BIBP 3226 trifluoroacetate empowers researchers with pinpoint NPY Y1 and NPFF receptor blockade, streamlining complex coculture and signaling workflows. Its robust affinity and protocol flexibility are redefining anxiety, analgesia, and cardiovascular regulation research—especially where mechanistic clarity and experimental reproducibility are at a premium.

450 records 11/30 page Previous Next First page 上5页 1112131415 下5页 Last page